Donald J. Santel
Board Member
Jade Biosciences, Inc. (JBIO)Equibles does not estimate personal net worth.
Get an email with a short summary when Jade Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get JBIO alertsAbout Donald J. Santel
Donald J. Santel is recorded as Board Member at Jade Biosciences, Inc. (JBIO) since January 19, 2023. Jade Biosciences, Inc. reported in an 8-K filed May 1, 2025 that Donald J. Santel resigned as Aerovate's board of directors, effective April 28, 2025. Jade Biosciences, Inc. reported in an 8-K filed January 23, 2023 that Donald J. Santel was appointed member of the Board, effective January 19, 2023. Jade Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Jade Biosciences, Inc. includes Tom Frohlich (CEO and Board Member), Eric Dobmeier (Chairman and Board Member), Bradford Dahms (CFO) and 7 others.
“On April 28, 2025, Timothy Noyes, Habib Dable, Allison Dorval, David Grayzel, M.D., Mark Iwicki, Joshua Resnick, M.D. and Donald Santel resigned from Aerovate's board of directors and its committees on which they respectively served, which resignations were not the result of any disagreements with the Company relating to the Company's operations, policies or practices.”
“Effective as of January 19, 2023 (the "Effective Date"), upon the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the "Board") of Aerovate Therapeutics, Inc. (the "Company"), the Board appointed Donald J. Santel as a member of the Board.”
Affiliation history
-
Current
2023-01-19–present
-
2023-01-19–2025-04-28
Company network
Leadership on record at Jade Biosciences, Inc.
- Tom Frohlich CEO, Board Member
- Eric Dobmeier Chairman, Board Member
- Bradford Dahms CFO
- Benjamin T. Dake COO
- Andrew King CTO
- Elizabeth Balta General Counsel
- Christopher Cain Board Member
- Continuing Directors Board Member
- Erin Lavelle Board Member
- Habib J. Dable Board Member